Article
Genetic evaluation of AMPD1, CPT2, and PGYM metabolic enzymes in patients with chronic fatigue syndrome.
Genetics and molecular research : GMR - 29 Jul 2016
Maltese P E, Venturini L, Poplavskaya E, Bertelli M, Cecchin S, Granato M, Nikulina S Y, Salmina A, Aksyutina N, Capelli E, Ricevuti G, Lorusso L
Abstract excerpt
Chronic fatigue syndrome (CFS) is a disease that can seriously impair one's quality of life; patients complain of excessive fatigue and myalgia following physical exertion. This disease may be associated with abnormalities in genes affecting exercise tolerance and physical performance. Adenosine monophosphate deaminase (AMPD1), carnitine palmitoyltransferase II (CPT2), and the muscle isoform of glycogen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
